Overview Fundamentals API Earnings EOD API Sample Code Pricing

Syngene International Limited (SYNGENE NSE) stock market data APIs

INR918 19.55(2.2%) as of November 8, 2024
Price chart is built with Anychart

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing and sterile fill-finish services. It also provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

Syngene International Limited Financial Data Overview

898.45
918
-
920
894.3
606.5791-945.25
360 446 M
74.6221
401 M
34 511 M
2.64
0.0014
0.585
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SYNGENE',
Type: 'Common Stock',
Name: 'Syngene International Limited',
Exchange: 'NSE',
CurrencyCode: 'INR',
CurrencyName: 'Indian Rupee',
CurrencySymbol: 'INR',
CountryName: 'India',
CountryISO: 'IN',
OpenFigi: NULL,
ISIN: 'INE398R01022',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
}

Syngene International Limited Fundamental Data is available in our Financial Data APIs

  • Net Revenue 34 511 M
  • EBITDA 9 444 M
  • Earnings Per Share 12.04
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Syngene International Limited Earnings via APIs

  • Latest Release 2024-10-23
  • EPS/Forecast 2.55

Get Syngene International Limited End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com